CanadaVarious Aved (Labtician Ophthalmics) ophthalmic solutions — including Atropine Sulfate (0.01%, 0.02%, 0.025%, 0.05%), Fluorescein Na/Proparacaine, Insulin Regular 25 IU/mL ophthalmic solution, Mitomycin 0.04% (PF), Moxifloxacin injection, and a Prednisolone/Moxifloxacin/Bromfenac solution — sold nationally in Canada are affected and can be identified by their product names and listed lot numbers. They were recalled because they were sold without market authorization (DIN) in Canada due to third‑party branding. Verify whether your product is affected, consult your healthcare provider before stopping use, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers, Health Care Establishments
Companies: Aved, 44 Richmond St. West, Unit 202,, Oshawa, Ontario, L1G 1C7.
How to identify it
Brand: Labtician Ophthalmics, Inc. / Aved; Product Name: Atropine Sulfate 0.01% Ophthalmic Solution, 5 mL; Market Authorization: No market authorization; Dosage Form: Solution; Strength: Atropine Sulfate 0.01%; Lot Number: 11122025@5, 01052026@11
Brand: Labtician Ophthalmics, Inc. / Aved; Product Name: Atropine Sulfate 0.02% Ophthalmic Solution, 5 mL; Market Authorization: No market authorization; Dosage Form: Solution; Strength: Atropine Sulfate 0.02%; Lot Number: 10162025@3, 12052025@5, 01272026@13
Brand: Labtician Ophthalmics, Inc. / Aved; Product Name: Atropine Sulfate 0.025% Ophthalmic Solution, 5 mL; Market Authorization: No market authorization; Dosage Form: Solution; Strength: Atropine Sulfate 0.025%; Lot Number: 10162025@5, 12082025@12, 01272026@14, 02252026@5
Brand: Labtician Ophthalmics, Inc. / Aved; Product Name: Atropine Sulfate 0.05% Ophthalmic Solution, 5 mL; Market Authorization: No market authorization; Dosage Form: Solution; Strength: Atropine Sulfate 0.05%; Lot Number: 10022025@3, 11202025@8, 01152026@6, 02042026@14
Brand: Labtician Ophthalmics, Inc. / Aved; Product Name: Fluorescein Na 0.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 5 mL; Market Authorization: No market authorization; Dosage Form: Solution; Strength: Fluorescein Na 0.25% / Proparacaine HCl 0.5%; Lot Number: 11202025@5, 12082025@11, 12232025@2, 01212026@10
Brand: Labtician Ophthalmics, Inc. / Aved; Product Name: Insulin Regular (Human) 25 IU/mL Ophthalmic Solution, 10 mL; Market Authorization: No market authorization; Dosage Form: Solution; Strength: Insulin 25 IU/mL; Lot Number: 10232025@3, 11142025@4, 12112025@3, 01222026@8
Brand: Labtician Ophthalmics, Inc. / Aved; Product Name: Mitomycin 0.04% Ophthalmic Solution (PF), 0.75 mL; Market Authorization: No market authorization; Dosage Form: Solution; Strength: Mitomycin 0.04%; Lot Number: 01192026@8
Brand: Labtician Ophthalmics, Inc. / Aved; Product Name: Moxifloxacin HCl 150 mcg/0.1 mL Ophthalmic Injection Solution, 0.75 mL; Market Authorization: No market authorization; Dosage Form: Solution; Strength: Moxifloxacin HCl 150 mcg/0.1 mL; Lot Number: 01192026@8
Brand: Labtician Ophthalmics, Inc. / Aved; Product Name: Prednisolone Sodium Phosphate 1% / Moxifloxacin 0.5% / Bromfenac 0.075%; Market Authorization: No market authorization; Dosage Form: Solution; Strength: Prednisolone Sodium Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075%; Lot Number: 12162026@11
The hazard
Products sold without market authorization (DIN) in Canada due to third-party branding.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)